Wolverine Trading, LLC Athersys, Inc Call Options Transaction History

Wolverine Trading, LLC

17 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	BUY	$0.18 - $0.86 $6,786 - $32,422	37,700 New	37,700 $11,000
Q1 2022 May 16, 2022	SELL	$0.6 - $1.06 $16,560 - $29,256	-27,600 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$0.85 - $1.4 $26,860 - $44,240	-31,600 Reduced 53.38%	27,600 $24,000
Q3 2021 Nov 12, 2021	BUY	$1.33 - $1.77 $6,783 - $9,027	5,100 Added 9.43%	59,200 $81,000
Q2 2021 Aug 06, 2021	BUY	$1.41 - $1.94 $15,087 - $20,758	10,700 Added 24.65%	54,100 $76,000
Q1 2021 May 14, 2021	BUY	$1.61 - $2.77 $20,608 - $35,456	12,800 Added 41.83%	43,400 $71,000
Q4 2020 Feb 12, 2021	BUY	$1.55 - $2.24 $20,150 - $29,120	13,000 Added 73.86%	30,600 $57,000
Q3 2020 Nov 13, 2020	SELL	$1.91 - $3.08 $6,876 - $11,088	-3,600 Reduced 16.98%	17,600 $36,000
Q1 2020 May 11, 2020	BUY	$1.17 - $3.0 $3,744 - $9,600	3,200 Added 17.78%	21,200 $55,000
Q3 2019 Nov 14, 2019	SELL	$1.21 - $1.65 $21,901 - $29,865	-18,100 Reduced 50.14%	18,000 $24,000
Q2 2019 Aug 20, 2019	BUY	$1.39 - $2.03 $25,298 - $36,946	18,200 Added 101.68%	36,100 $61,000
Q1 2019 May 15, 2019	BUY	$1.39 - $1.71 $4,309 - $5,301	3,100 Added 20.95%	17,900 $27,000
Q4 2018 Feb 14, 2019	SELL	$1.41 - $2.16 $17,907 - $27,432	-12,700 Reduced 46.18%	14,800 $21,000
Q3 2018 Nov 14, 2018	SELL	$1.86 - $2.18 $4,836 - $5,668	-2,600 Reduced 8.64%	27,500 $58,000
Q1 2018 May 15, 2018	BUY	$1.34 - $2.03 $40,334 - $61,102	30,100 New	30,100 $55,000
Q4 2017 Feb 14, 2018	SELL	$1.65 - $2.45 $55,935 - $83,055	-33,900 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$1.5 - $2.55 $50,850 - $86,445	33,900	33,900 $70,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.